Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial.
Identifieur interne : 000223 ( France/Analysis ); précédent : 000222; suivant : 000224Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial.
Auteurs : T. Gauthier [France] ; A. Garuchet-Bigot ; B. Marin ; J. Mollard ; O. Loum ; V. Fermeaux ; I. Jammet ; D. Kanoun ; A. Maubon ; Y. AubardSource :
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [ 1532-2157 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aisselle, Exsudats et transsudats (), Femelle, Gels, Humains, Invasion tumorale (anatomopathologie), Jeune adulte, Lymphadénectomie (), Lymphadénectomie (effets indésirables), Lymphe (), Lymphoedème (), Lymphoedème (étiologie), Mastectomie (), Méthode en double aveugle, Noeuds lymphatiques (), Noeuds lymphatiques (anatomopathologie), Peptides cycliques (usage thérapeutique), Résultat thérapeutique, Soins préopératoires (), Somatostatine (analogues et dérivés), Somatostatine (usage thérapeutique), Stade de la tumeur, Statistique non paramétrique, Sujet âgé, Sujet âgé de 80 ans ou plus, Sérome (), Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Valeurs de référence, Études de suivi, Études prospectives, Évaluation des risques.
- MESH :
- analogues et dérivés : Somatostatine.
- anatomopathologie : Invasion tumorale, Noeuds lymphatiques, Tumeurs du sein.
- effets indésirables : Lymphadénectomie.
- usage thérapeutique : Peptides cycliques, Somatostatine.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Aisselle, Exsudats et transsudats, Femelle, Gels, Humains, Jeune adulte, Lymphadénectomie, Lymphe, Lymphoedème, Mastectomie, Méthode en double aveugle, Noeuds lymphatiques, Résultat thérapeutique, Soins préopératoires, Stade de la tumeur, Statistique non paramétrique, Sujet âgé, Sujet âgé de 80 ans ou plus, Sérome, Tumeurs du sein, Valeurs de référence, Études de suivi, Études prospectives, Évaluation des risques.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Axilla, Breast Neoplasms (pathology), Breast Neoplasms (surgery), Double-Blind Method, Exudates and Transudates (drug effects), Female, Follow-Up Studies, Gels, Humans, Lymph (drug effects), Lymph Node Excision (adverse effects), Lymph Node Excision (methods), Lymph Nodes (pathology), Lymph Nodes (surgery), Lymphedema (etiology), Lymphedema (prevention & control), Mastectomy (methods), Middle Aged, Neoplasm Invasiveness (pathology), Neoplasm Staging, Peptides, Cyclic (therapeutic use), Preoperative Care (methods), Prospective Studies, Reference Values, Risk Assessment, Seroma (prevention & control), Somatostatin (analogs & derivatives), Somatostatin (therapeutic use), Statistics, Nonparametric, Treatment Outcome, Young Adult.
- MESH :
- chemical , analogs & derivatives : Somatostatin.
- chemical , therapeutic use : Peptides, Cyclic, Somatostatin.
- chemical : Gels.
- adverse effects : Lymph Node Excision.
- drug effects : Exudates and Transudates, Lymph.
- etiology : Lymphedema.
- methods : Lymph Node Excision, Mastectomy, Preoperative Care.
- pathology : Breast Neoplasms, Lymph Nodes, Neoplasm Invasiveness.
- prevention & control : Lymphedema, Seroma.
- surgery : Breast Neoplasms, Lymph Nodes.
- Adult, Aged, Aged, 80 and over, Axilla, Double-Blind Method, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Staging, Prospective Studies, Reference Values, Risk Assessment, Statistics, Nonparametric, Treatment Outcome, Young Adult.
Abstract
The aim of this study was to assess the efficacy of Lanreotide Autogel 90 mg PR to prevent lymphorrhea after axillary dissection in breast cancer.
DOI: 10.1016/j.ejso.2012.05.009
PubMed: 22703757
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002079
- to stream PubMed, to step Curation: 002079
- to stream PubMed, to step Checkpoint: 002079
- to stream Ncbi, to step Merge: 004E62
- to stream Ncbi, to step Curation: 004E62
- to stream Ncbi, to step Checkpoint: 004E62
- to stream Main, to step Merge: 004218
- to stream Main, to step Curation: 004202
- to stream Main, to step Exploration: 004202
- to stream France, to step Extraction: 000223
Links to Exploration step
pubmed:22703757Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial.</title>
<author><name sortKey="Gauthier, T" sort="Gauthier, T" uniqKey="Gauthier T" first="T" last="Gauthier">T. Gauthier</name>
<affiliation wicri:level="3"><nlm:affiliation>CHU Limoges, Hopital Mère-Enfant, Institut du Sein, av Larrey, Limoges F-87000, France. gauthiertristan@yahoo.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CHU Limoges, Hopital Mère-Enfant, Institut du Sein, av Larrey, Limoges F-87000</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Limousin</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garuchet Bigot, A" sort="Garuchet Bigot, A" uniqKey="Garuchet Bigot A" first="A" last="Garuchet-Bigot">A. Garuchet-Bigot</name>
</author>
<author><name sortKey="Marin, B" sort="Marin, B" uniqKey="Marin B" first="B" last="Marin">B. Marin</name>
</author>
<author><name sortKey="Mollard, J" sort="Mollard, J" uniqKey="Mollard J" first="J" last="Mollard">J. Mollard</name>
</author>
<author><name sortKey="Loum, O" sort="Loum, O" uniqKey="Loum O" first="O" last="Loum">O. Loum</name>
</author>
<author><name sortKey="Fermeaux, V" sort="Fermeaux, V" uniqKey="Fermeaux V" first="V" last="Fermeaux">V. Fermeaux</name>
</author>
<author><name sortKey="Jammet, I" sort="Jammet, I" uniqKey="Jammet I" first="I" last="Jammet">I. Jammet</name>
</author>
<author><name sortKey="Kanoun, D" sort="Kanoun, D" uniqKey="Kanoun D" first="D" last="Kanoun">D. Kanoun</name>
</author>
<author><name sortKey="Maubon, A" sort="Maubon, A" uniqKey="Maubon A" first="A" last="Maubon">A. Maubon</name>
</author>
<author><name sortKey="Aubard, Y" sort="Aubard, Y" uniqKey="Aubard Y" first="Y" last="Aubard">Y. Aubard</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22703757</idno>
<idno type="pmid">22703757</idno>
<idno type="doi">10.1016/j.ejso.2012.05.009</idno>
<idno type="wicri:Area/PubMed/Corpus">002079</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002079</idno>
<idno type="wicri:Area/PubMed/Curation">002079</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002079</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002079</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002079</idno>
<idno type="wicri:Area/Ncbi/Merge">004E62</idno>
<idno type="wicri:Area/Ncbi/Curation">004E62</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004E62</idno>
<idno type="wicri:Area/Main/Merge">004218</idno>
<idno type="wicri:Area/Main/Curation">004202</idno>
<idno type="wicri:Area/Main/Exploration">004202</idno>
<idno type="wicri:Area/France/Extraction">000223</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial.</title>
<author><name sortKey="Gauthier, T" sort="Gauthier, T" uniqKey="Gauthier T" first="T" last="Gauthier">T. Gauthier</name>
<affiliation wicri:level="3"><nlm:affiliation>CHU Limoges, Hopital Mère-Enfant, Institut du Sein, av Larrey, Limoges F-87000, France. gauthiertristan@yahoo.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CHU Limoges, Hopital Mère-Enfant, Institut du Sein, av Larrey, Limoges F-87000</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Limousin</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garuchet Bigot, A" sort="Garuchet Bigot, A" uniqKey="Garuchet Bigot A" first="A" last="Garuchet-Bigot">A. Garuchet-Bigot</name>
</author>
<author><name sortKey="Marin, B" sort="Marin, B" uniqKey="Marin B" first="B" last="Marin">B. Marin</name>
</author>
<author><name sortKey="Mollard, J" sort="Mollard, J" uniqKey="Mollard J" first="J" last="Mollard">J. Mollard</name>
</author>
<author><name sortKey="Loum, O" sort="Loum, O" uniqKey="Loum O" first="O" last="Loum">O. Loum</name>
</author>
<author><name sortKey="Fermeaux, V" sort="Fermeaux, V" uniqKey="Fermeaux V" first="V" last="Fermeaux">V. Fermeaux</name>
</author>
<author><name sortKey="Jammet, I" sort="Jammet, I" uniqKey="Jammet I" first="I" last="Jammet">I. Jammet</name>
</author>
<author><name sortKey="Kanoun, D" sort="Kanoun, D" uniqKey="Kanoun D" first="D" last="Kanoun">D. Kanoun</name>
</author>
<author><name sortKey="Maubon, A" sort="Maubon, A" uniqKey="Maubon A" first="A" last="Maubon">A. Maubon</name>
</author>
<author><name sortKey="Aubard, Y" sort="Aubard, Y" uniqKey="Aubard Y" first="Y" last="Aubard">Y. Aubard</name>
</author>
</analytic>
<series><title level="j">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</title>
<idno type="eISSN">1532-2157</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Axilla</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Double-Blind Method</term>
<term>Exudates and Transudates (drug effects)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Gels</term>
<term>Humans</term>
<term>Lymph (drug effects)</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymph Node Excision (methods)</term>
<term>Lymph Nodes (pathology)</term>
<term>Lymph Nodes (surgery)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (prevention & control)</term>
<term>Mastectomy (methods)</term>
<term>Middle Aged</term>
<term>Neoplasm Invasiveness (pathology)</term>
<term>Neoplasm Staging</term>
<term>Peptides, Cyclic (therapeutic use)</term>
<term>Preoperative Care (methods)</term>
<term>Prospective Studies</term>
<term>Reference Values</term>
<term>Risk Assessment</term>
<term>Seroma (prevention & control)</term>
<term>Somatostatin (analogs & derivatives)</term>
<term>Somatostatin (therapeutic use)</term>
<term>Statistics, Nonparametric</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aisselle</term>
<term>Exsudats et transsudats ()</term>
<term>Femelle</term>
<term>Gels</term>
<term>Humains</term>
<term>Invasion tumorale (anatomopathologie)</term>
<term>Jeune adulte</term>
<term>Lymphadénectomie ()</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphe ()</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (étiologie)</term>
<term>Mastectomie ()</term>
<term>Méthode en double aveugle</term>
<term>Noeuds lymphatiques ()</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Peptides cycliques (usage thérapeutique)</term>
<term>Résultat thérapeutique</term>
<term>Soins préopératoires ()</term>
<term>Somatostatine (analogues et dérivés)</term>
<term>Somatostatine (usage thérapeutique)</term>
<term>Stade de la tumeur</term>
<term>Statistique non paramétrique</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Sérome ()</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Valeurs de référence</term>
<term>Études de suivi</term>
<term>Études prospectives</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Somatostatin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Peptides, Cyclic</term>
<term>Somatostatin</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Gels</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Somatostatine</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Invasion tumorale</term>
<term>Noeuds lymphatiques</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Exudates and Transudates</term>
<term>Lymph</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term>
<term>Mastectomy</term>
<term>Preoperative Care</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymph Nodes</term>
<term>Neoplasm Invasiveness</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term>
<term>Seroma</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymph Nodes</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Peptides cycliques</term>
<term>Somatostatine</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Axilla</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Prospective Studies</term>
<term>Reference Values</term>
<term>Risk Assessment</term>
<term>Statistics, Nonparametric</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aisselle</term>
<term>Exsudats et transsudats</term>
<term>Femelle</term>
<term>Gels</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Lymphadénectomie</term>
<term>Lymphe</term>
<term>Lymphoedème</term>
<term>Mastectomie</term>
<term>Méthode en double aveugle</term>
<term>Noeuds lymphatiques</term>
<term>Résultat thérapeutique</term>
<term>Soins préopératoires</term>
<term>Stade de la tumeur</term>
<term>Statistique non paramétrique</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Sérome</term>
<term>Tumeurs du sein</term>
<term>Valeurs de référence</term>
<term>Études de suivi</term>
<term>Études prospectives</term>
<term>Évaluation des risques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The aim of this study was to assess the efficacy of Lanreotide Autogel 90 mg PR to prevent lymphorrhea after axillary dissection in breast cancer.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Limousin</li>
<li>Nouvelle-Aquitaine</li>
</region>
</list>
<tree><noCountry><name sortKey="Aubard, Y" sort="Aubard, Y" uniqKey="Aubard Y" first="Y" last="Aubard">Y. Aubard</name>
<name sortKey="Fermeaux, V" sort="Fermeaux, V" uniqKey="Fermeaux V" first="V" last="Fermeaux">V. Fermeaux</name>
<name sortKey="Garuchet Bigot, A" sort="Garuchet Bigot, A" uniqKey="Garuchet Bigot A" first="A" last="Garuchet-Bigot">A. Garuchet-Bigot</name>
<name sortKey="Jammet, I" sort="Jammet, I" uniqKey="Jammet I" first="I" last="Jammet">I. Jammet</name>
<name sortKey="Kanoun, D" sort="Kanoun, D" uniqKey="Kanoun D" first="D" last="Kanoun">D. Kanoun</name>
<name sortKey="Loum, O" sort="Loum, O" uniqKey="Loum O" first="O" last="Loum">O. Loum</name>
<name sortKey="Marin, B" sort="Marin, B" uniqKey="Marin B" first="B" last="Marin">B. Marin</name>
<name sortKey="Maubon, A" sort="Maubon, A" uniqKey="Maubon A" first="A" last="Maubon">A. Maubon</name>
<name sortKey="Mollard, J" sort="Mollard, J" uniqKey="Mollard J" first="J" last="Mollard">J. Mollard</name>
</noCountry>
<country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Gauthier, T" sort="Gauthier, T" uniqKey="Gauthier T" first="T" last="Gauthier">T. Gauthier</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000223 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000223 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= France |étape= Analysis |type= RBID |clé= pubmed:22703757 |texte= Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i -Sk "pubmed:22703757" \ | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |